Papers
13
Total Citations
146
H-Index
6
About
Kyrollis Attalla is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes in robot-assisted urologic oncology, particularly for kidney and bladder cancers. His major contributions include challenging long-held assumptions about warm ischemia time in partial nephrectomy—his 2018 study (45 citations) demonstrated that this metric may not be the primary predictor of renal function, reshaping surgical decision-making. Attalla has also pioneered nonopioid recovery protocols for radical cystectomy patients, with a 2019 prospective study (34 citations) showing reduced opioid use without compromising pain control. His recent work on apixaban for venous thromboembolism prophylaxis (2023, 15 citations) and antibiogram-directed infection prevention (2023, 6 citations) reflects a systematic approach to improving perioperative care. Beyond clinical innovation, Attalla contributed to surgical education through a dedicated robot-assisted surgery training program (2013, 13 citations). His comparative analyses of robotic versus open cystectomy and investigations into immunotherapy-based neoadjuvant treatment (2025, 4 citations) continue to inform evidence-based practice. With over 130 cumulative citations, Attalla’s research is shaping safer, more effective surgical protocols in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Effectiveness of a dedicated robot-assisted surgery training program.13 citations · 2013
- 5
- 6
- 7
- 8
- 9
- 10